Martí Cortey

CReSA – IRTA - Spain Author

He obtained his degree in Biology (1997) at the Universitat de Girona where he started his career in population genetics and molecular evolution. He did his master (2000) and the PhD (2005) at the Genetics Unit. During that period, he acquired vast population genetics, phylogeny, molecular evolution and bioinformatics analysis skills and an in deep technological knowledge of sequence, microsatellite and protein loci data generation.

During his first post-doc at CReSA (Barcelona, Spain), he applied his expertise in population genetics and evolution to the Veterinary field. The analysis developed to study vertebrate evolutionary relationships had barely been exploited to study viral evolution and strain distribution. He focused his research in applying these analysis methodologies to Porcine Circovirus type 2, one of the most important pathogens for domestic swine worldwide. In 2010, he moved to the National Veterinary Institute (SVA, Uppsala, Sweden), applying his knowledge on viral genetic variability to the development of new diagnostic tools based on the PCR technology that may have direct applicability in the veterinary field. In 2012, he was awarded with a grant from the Infectiopôle Sud Foundation to deepen his bioinformatics skills in post-doctoral stage training at the Unit of Molecular Virology, Emergence and Viral Co-evolution (UMR CNRS 7268, Marseille, France). He was responsible for designing and automating protocols to detect unknown viruses using Next Generation sequencing technology. In 2013, he started working at the Biosecurity Level 3 facilities of the Pirbright Institute (Pirbright, UK) studying the persistence of foot-and-mouth disease virus in African buffalo. Nowadays, he is a Researcher at IRTA-CReSA (Bellaterra, Spain). Using a multidisciplinary approach, he is working to improve the protective immunity against Porcine Respiratory and Reproductive Syndrome Virus, in order to enhance the competitiveness of the Spanish swine industry.

He has vast knowledge in virology, population genetics, molecular evolution and bioinformatics, and a deep technological knowledge of Sanger and Next Generation sequencing, that have lots of applications to the veterinary field studying viral evolution, pathogenicity and strain distribution. He actively participated in 10 national and 6 international R&D&I projects funded in competitive calls, he has published more than 50 peer-reviewed scientific papers and book chapters, and more than 40 oral and poster communications in national and international congresses. He is also a member of the International Committee on Taxonomy of Viruses and the Catalan Society of Biology.

Updated CV 09-Apr-2016

TwitterLinkedinTelegramTelegram
Three months pigs with PCV2-SD. Note the marked spine, indicative of growth retardation, and body pallor

The challenge of Porcine Circovirus type 2 (PCV2) intra-specific taxonomic classification

All available vaccines in the European and North-American market are based on PCV2a genotype, while the most prevalent ones are PCV2b and PCV2d ones. Although significant level of cross-protection among these three genotypes has been demonstrated, it would be interesting to assess if vaccine efficiency would be equivalent in front of all these different genotypes.

Likecomment
share
My favorites

Welcome to 333

Connect, share, and interact with the largest community of professionals in the swine industry.

Celebrating 153586Users on 333!

Sign upAlready a member?
Recommended accounts
Zhou  Lydia

Zhou Lydia

Other - China
DAVI  LIOU

DAVI LIOU

Other - China
pig333

pig333

Company - Spain
Idexx

Idexx

Company - Netherlands
Boehringer Ingelheim Vetmedica GmbH
Company - Germany